Accelerate Diagnostics Announces Closing of $79.3 Million Upsized Offering

May 15, 2017 — Accelerate Diagnostics, Inc. (Nasdaq:AXDX) announced the closing of its previously announced underwritten public offering of 2,750,000 shares of its common stock today, upsized from the original share offering of 2,500,000 shares of common stock, at a previously disclosed public offering price of $28.85 per share. The gross proceeds to Accelerate Diagnostics from the offering are approximately $79.3 million before deducting underwriting commissions and discounts, and estimated offering expenses payable by the company.

Continue reading


Accelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017

May 03, 2017 — Accelerate Diagnostics, Inc. today announced preliminary financial results for the quarter ending March 31, 2017 including signed customer evaluation contracts covering 169 instruments, 22 additional instruments converted into revenue generating placements, and revenue growth exceeding 325% of the same period in the prior year.

Continue reading


Accelerate Diagnostics Schedules Call to Review First Quarter 2017 Results for May 3rd

Apr 18, 2017 — Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 3rd, 2017 to discuss its first quarter 2017 financial results and commercial progress.

Continue reading


Fourth Quarter and Full Year 2016 Financial Results

Feb 28, 2017 — Accelerate Diagnostics filed Fourth Quarter and Full Year 2016 financial results today. Access them directly on our website in the SEC filings section of our Investors page or through the Securities and Exchange Commission’s (SEC) website.

Continue reading


See all news
Media kit
Media contact

Andy Chasteen
520.365.3100
achasteen@axdx.com


Company information

About the company
Bios
Our products


Digital assets

Enter your email address below for access to photos, logos and videos.

See Terms and Use Policy


Connect with us

  Like us on Facebook
  Follow us on Twitter
  See us on Linkedin
  Visit us on Google+

Upcoming Events
MAD-ID Annual Meeting

May 10–13, 2017
Orlando, FL

Learn more

ASM Microbe 2017

June 1–5, 2017
New Orleans

Learn more

IDWeek 2017

October 4–8, 2017
San Diego

Learn more

Past Events
ECCMID 2017

April 22–25, 2017
Vienna, Austria

Learn more

CLMA 2017

March 26–28, 2017
Nashville, TN

Learn more

ISICEM 2017

March 21–27, 2017
Brussels, Belgium

Learn more

Reanimation 2017

11 au 13 Janvier 2017
Porte de Versailles a Paris

Learn more

RICAI 2016

12-13 Décembre 2016
Palais des Congrès de Paris

Learn more

SEACM 2016

November 3-5, 2016
Atlanta, GA

Learn more

IDWeek 2016

October 26–30, 2016
New Orleans

Learn more

SWACM 2016

September 7–10, 2016
Fort Worth, TX

Learn more

ASM Microbe 2016

June 16–20, 2016
Boston

Learn more

ECCMID 2016

April 9–12, 2016
Amsterdam

Learn more

Over the past several years, Accelerate Diagnostics, together with our scientific collaborators, conducted numerous scientific studies supporting the exciting capabilities of our ID/AST System. Many of these studies resulted in posters presented at international conferences and peer-reviewed publications. We have conducted over 87,000 internal identification and susceptibility experiments across a panel of more than 20 of the most clinically prevalent species in sample types such as positive blood cultures and BALs. These studies demonstrated compelling performance versus reference and comparator methods, the results of which have been consistently duplicated by our clinical research partners. Below you will find links to some of these posters and publications.

Jun 18, 2016

Reproducibility of the Accelerate ID/AST Blood Culture Assay at Multiple Clinical Sites
ASM 2016

May 01, 2015

Rapid identification and antimicrobial susceptibility testing of bacteria in bloodstream infections using the Accelerate ID/AST technology

Apr 27, 2015

Performance of the new Accelerate ID/AST System in highly resistant Acinetobacter baumannii bloodstream infection isolates, compared to routine laboratory testing

Apr 23, 2015

Performance of the new Accelerate ID/AST System in highly resistant Acinetobacter baumannii bloodstream infection isolates, compared to routine laboratory testing
ECCMID 2015, COPENHAGEN, DENMARK, EPOSTER

See all publications

Get some

Support

Learn about our

Technology